Divergent mechanisms of steroid inhibition in the human ρ1 GABA


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 12 04 2024
accepted: 19 08 2024
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: epublish

Résumé

ρ-type γ-aminobutyric acid-A (GABA

Identifiants

pubmed: 39242530
doi: 10.1038/s41467-024-51904-7
pii: 10.1038/s41467-024-51904-7
doi:

Substances chimiques

Pregnenolone 73R90F7MQ8
Receptors, GABA-A 0
pregnenolone sulfate 04Y4D91RG0
Estradiol 4TI98Z838E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7795

Subventions

Organisme : Vetenskapsrådet (Swedish Research Council)
ID : 2019-02433, 2021-05806
Organisme : Stockholms Universitet (Stockholm University)
ID : FV-5.1.2-0523-19

Informations de copyright

© 2024. The Author(s).

Références

Howard, R. J. Elephants in the dark: Insights and incongruities in pentameric ligand-gated ion channel models. J. Mol. Biol. 433, 167128 (2021).
pubmed: 34224751 doi: 10.1016/j.jmb.2021.167128
Drew, C. A., Johnston, G. A. R. & Weatherby, R. P. Bicuculline-insensitive GABA receptors: Studies on the binding of (−)-baclofen to rat cerebellar membranes. Neurosci. Lett. 52, 317–321 (1984).
pubmed: 6097844 doi: 10.1016/0304-3940(84)90181-2
Enz, R. & Cutting, G. R. GABAC receptor ρ subunits are heterogeneously expressed in the human CNS and form homo‐ and heterooligomers with distinct physical properties. Eur. J. Neurosci. 11, 41–50 (1999).
pubmed: 9987010 doi: 10.1046/j.1460-9568.1999.00423.x
Johnston, G. Medicinal chemistry and molecular pharmacology of GABA-C receptors. Curr. Top. Med. Chem. 2, 903–913 (2002).
pubmed: 12171579 doi: 10.2174/1568026023393453
Varman, D. R., Soria-Ortíz, M. B., Martínez-Torres, A. & Reyes-Haro, D. GABAρ3 expression in lobule X of the cerebellum is reduced in the valproate model of autism. Neurosci. Lett. 687, 158–163 (2018).
pubmed: 30261230 doi: 10.1016/j.neulet.2018.09.042
Van Nieuwenhuijzen, P. S. et al. Targeting GABAC receptors improves post-stroke motor recovery. Brain Sci. 11, 315 (2021).
pubmed: 33801560 pmcid: 8000079 doi: 10.3390/brainsci11030315
Johnston, G., Chebib, M., Hanrahan, J. & Mewett, K. GABAC Receptors as drug targets. Curr. Drug Target CNS Neurol. Disord. 2, 260–268 (2003).
doi: 10.2174/1568007033482805
Cowgill, J. et al. Structure and dynamics of differential ligand binding in the human ρ-type GABAA receptor. Neuron 111, 3450–3464 (2023).
pubmed: 37659407 doi: 10.1016/j.neuron.2023.08.006
Morris, K. D., Moorefield, C. N. & Amin, J. Differential modulation of the gamma-aminobutyric acid type C receptor by neuroactive steroids. Mol. Pharmacol. 56, 752–759 (1999).
pubmed: 10496958
Legesse, D. H. et al. Structural insights into opposing actions of neurosteroids on GABAA receptors. Nat. Commun. 14, 5091 (2023).
pubmed: 37607940 pmcid: 10444788 doi: 10.1038/s41467-023-40800-1
Sun, C., Zhu, H., Clark, S. & Gouaux, E. Cryo-EM structures reveal native GABAA receptor assemblies and pharmacology. Nature 622, 195–201 (2023).
pubmed: 37730991 pmcid: 10550821 doi: 10.1038/s41586-023-06556-w
Marecki, R., Kałuska, J., Kolanek, A., Hakało, D. & Waszkiewicz, N. Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review. Front. Psychiatry 14, 1298359 (2023).
pubmed: 38116383 pmcid: 10729607 doi: 10.3389/fpsyt.2023.1298359
Li, W., Jin, X., Covey, D. F. & Steinbach, J. H. Neuroactive steroids and human recombinant rho1 GABAC receptors. J. Pharmacol. Exp. Ther. 323, 236–247 (2007).
pubmed: 17636008 doi: 10.1124/jpet.107.127365
Schumacher, M. et al. Pregnenolone sulfate in the brain: a controversial neurosteroid. Neurochem. Int. 52, 522–540 (2008).
pubmed: 18068870 doi: 10.1016/j.neuint.2007.08.022
Majewska, M. D., Mienville, J. M. & Vicini, S. Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons. Neurosci. Lett. 90, 279–284 (1988).
pubmed: 3138576 doi: 10.1016/0304-3940(88)90202-9
Wang, M.-D., Rahman, M., Zhu, D., Johansson, I.-M. & Bäckström, T. 3Beta-hydroxysteroids and pregnenolone sulfate inhibit recombinant rat GABA(A) receptor through different channel property. Eur. J. Pharmacol. 557, 124–131 (2007).
pubmed: 17239367 doi: 10.1016/j.ejphar.2006.11.071
Seljeset, S., Bright, D. P., Thomas, P. & Smart, T. G. Probing GABAA receptors with inhibitory neurosteroids. Neuropharmacology 136, 23–36 (2018).
pubmed: 29447845 pmcid: 6018617 doi: 10.1016/j.neuropharm.2018.02.008
Akk, G., Bracamontes, J. & Steinbach, J. H. Pregnenolone sulfate block of GABA(A) receptors: mechanism and involvement of a residue in the M2 region of the alpha subunit. J. Physiol. 532, 673–684 (2001).
pubmed: 11313438 pmcid: 2278584 doi: 10.1111/j.1469-7793.2001.0673e.x
Hall, J. E., Hall, M. E. & Guyton, A. C. Guyton and Hall Textbook of Medical Physiology. (Elsevier, Philadelphia, PA, 2021).
Douma, S. L., Husband, C., O’Donnell, M. E., Barwin, B. N. & Woodend, A. K. Estrogen-related mood disorders: reproductive life cycle factors. Adv. Nurs. Sci. 28, 364–375 (2005).
doi: 10.1097/00012272-200510000-00008
Greene, G. L. et al. Sequence and expression of human estrogen receptor complementary DNA. Science 231, 1150–1154 (1986).
pubmed: 3753802 doi: 10.1126/science.3753802
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S. & Gustafsson, J. A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925–5930 (1996).
pubmed: 8650195 pmcid: 39164 doi: 10.1073/pnas.93.12.5925
Prossnitz, E. R. et al. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 70, 165–190 (2008).
pubmed: 18271749 doi: 10.1146/annurev.physiol.70.113006.100518
Paradiso, K., Zhang, J. & Steinbach, J. H. The C terminus of the human nicotinic alpha4beta2 receptor forms a binding site required for potentiation by an estrogenic steroid. J. Neurosci. 21, 6561–6568 (2001).
pubmed: 11517245 pmcid: 6763114 doi: 10.1523/JNEUROSCI.21-17-06561.2001
Foy, M. R. et al. 17beta-estradiol enhances NMDA receptor-mediated EPSPs and long-term potentiation. J. Neurophysiol. 81, 925–929 (1999).
pubmed: 10036289 doi: 10.1152/jn.1999.81.2.925
Eaton, M. M., Lim, Y. B., Covey, D. F. & Akk, G. Modulation of the human ρ1 GABAA receptor by inhibitory steroids. Psychopharmacology 231, 3467–3478 (2014).
pubmed: 24317445 doi: 10.1007/s00213-013-3379-z
Germann, A. L. et al. Analysis of modulation of the ρ1 GABAA receptor by combinations of inhibitory and potentiating neurosteroids reveals shared and distinct binding sites. Mol. Pharmacol. 98, 280–291 (2020).
pubmed: 32675382 pmcid: 7472123 doi: 10.1124/mol.120.119842
Wójtowicz, T. & Mozrzymas, J. W. Estradiol and GABAergic transmission in the hippocampus. Vitam. Horm. 82, 279–300 (2010).
pubmed: 20472144 doi: 10.1016/S0083-6729(10)82015-1
Sivilotti, L. G. What single-channel analysis tells us of the activation mechanism of ligand-gated channels: the case of the glycine receptor. J. Physiol. 588, 45–58 (2010).
pubmed: 19770192 doi: 10.1113/jphysiol.2009.178525
Mukhtasimova, N., Lee, W. Y., Wang, H.-L. & Sine, S. M. Detection and trapping of intermediate states priming nicotinic receptor channel opening. Nature 459, 451–454 (2009).
pubmed: 19339970 pmcid: 2712348 doi: 10.1038/nature07923
Pierce, S. R., Germann, A. L., Steinbach, J. H. & Akk, G. The sulfated steroids pregnenolone sulfate and dehydroepiandrosterone sulfate inhibit the α1β3γ2L GABAA receptor by stabilizing a novel nonconducting state. Mol. Pharmacol. 101, 68–77 (2022).
pubmed: 34853153 pmcid: 8969134 doi: 10.1124/molpharm.121.000385
Woodhull, A. M. Ionic blockage of sodium channels in nerve. J. Gen. Physiol. 61, 687–708 (1973).
pubmed: 4541078 pmcid: 2203489 doi: 10.1085/jgp.61.6.687
Eisenman, L. N., He, Y., Fields, C., Zorumski, C. F. & Mennerick, S. Activation-dependent properties of pregnenolone sulfate inhibition of GABAA receptor-mediated current. J. Physiol. 550, 679–691 (2003).
pubmed: 12938673 pmcid: 2343070 doi: 10.1113/jphysiol.2003.043810
Mukherjee, J. et al. Estradiol modulates the efficacy of synaptic inhibition by decreasing the dwell time of GABAA receptors at inhibitory synapses. Proc. Natl. Acad. Sci. USA 114, 11763–11768 (2017).
pubmed: 29078280 pmcid: 5676881 doi: 10.1073/pnas.1705075114
Townsend, E. A., Miller, V. M. & Prakash, Y. S. Sex differences and sex steroids in lung health and disease. Endocr. Rev. 33, 1–47 (2012).
pubmed: 22240244 pmcid: 3365843 doi: 10.1210/er.2010-0031
Dalal, V. et al. Lipid nanodisc scaffold and size alter the structure of a pentameric ligand-gated ion channel. Nat. Commun. 15, 25 (2024).
pubmed: 38167383 pmcid: 10762164 doi: 10.1038/s41467-023-44366-w
Lyons, J. A., Bøggild, A., Nissen, P. & Frauenfeld, J. Saposin-lipoprotein scaffolds for structure determination of membrane transporters. Methods Enzymol. 594, 85–99 (2017).
pubmed: 28779844 doi: 10.1016/bs.mie.2017.06.035
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. ELife 7, e42166 (2018).
pubmed: 30412051 pmcid: 6250425 doi: 10.7554/eLife.42166
Grant, T., Rohou, A. & Grigorieff, N. cisTEM, user-friendly software for single-particle image processing. ELife 7, https://doi.org/10.7554/eLife.35383 (2018).
Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153–1160 (2019).
pubmed: 31591578 pmcid: 6858545 doi: 10.1038/s41592-019-0575-8
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
pubmed: 28165473 doi: 10.1038/nmeth.4169
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214–1221 (2020).
pubmed: 33257830 doi: 10.1038/s41592-020-00990-8
Casañal, A., Lohkamp, B. & Emsley, P. Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. Publ. Protein Soc. 29, 1069–1078 (2020).
doi: 10.1002/pro.3791
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010).
pubmed: 20124702 pmcid: 2815670 doi: 10.1107/S0907444909052925
Williams, C. J. et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. Publ. Protein Soc. 27, 293–315 (2018).
doi: 10.1002/pro.3330
Klesse, G., Rao, S., Sansom, M. S. P. & Tucker, S. J. CHAP: A versatile tool for the structural and functional annotation of ion channel pores. J. Mol. Biol. 431, 3353–3365 (2019).
pubmed: 31220459 pmcid: 6699600 doi: 10.1016/j.jmb.2019.06.003
Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. Publ. Protein Soc. 30, 70–82 (2021).
doi: 10.1002/pro.3943
Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859–1865 (2008).
pubmed: 18351591 doi: 10.1002/jcc.20945
Ingólfsson, H. I. et al. Computational lipidomics of the neuronal plasma membrane. Biophys. J. 113, 2271–2280 (2017).
pubmed: 29113676 pmcid: 5700369 doi: 10.1016/j.bpj.2017.10.017
Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71–73 (2017).
pubmed: 27819658 doi: 10.1038/nmeth.4067
Vanommeslaeghe, K. et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J. Comput. Chem. 31, 671–690 (2010).
pubmed: 19575467 pmcid: 2888302 doi: 10.1002/jcc.21367
Páll, S. et al. Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS. J. Chem. Phys. 153, 134110 (2020).
pubmed: 33032406 doi: 10.1063/5.0018516
Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007).
pubmed: 17212484 doi: 10.1063/1.2408420
Parrinello, M. & Rahman, A. Crystal structure and pair potentials: A molecular-dynamics study. Phys. Rev. Lett. 45, 1196–1199 (1980).
doi: 10.1103/PhysRevLett.45.1196
Hess, B. P-LINCS: A parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4, 116–122 (2008).
pubmed: 26619985 doi: 10.1021/ct700200b
Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577–8593 (1995).
doi: 10.1063/1.470117
Gowers, R. et al. MDAnalysis: A Python package for the rapid analysis of molecular dynamics simulations. In 98–105 https://doi.org/10.25080/Majora-629e541a-00e (Austin, Texas, 2016).
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 27–28 (1996).
doi: 10.1016/0263-7855(96)00018-5
Hunter, J. D. Matplotlib: A 2D graphics environment. Comput. Sci. Eng. 9, 90–95 (2007).
doi: 10.1109/MCSE.2007.55
Lindahl, V., Gourdon, P., Andersson, M. & Hess, B. Permeability and ammonia selectivity in aquaporin TIP2;1: linking structure to function. Sci. Rep. 8, 2995 (2018).
pubmed: 29445244 pmcid: 5813003 doi: 10.1038/s41598-018-21357-2

Auteurs

Chen Fan (C)

Dept. of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden.
Dept. of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, Sweden.

John Cowgill (J)

Dept. of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, Sweden.

Rebecca J Howard (RJ)

Dept. of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden. rebecca.howard@dbb.su.se.
Dept. of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, Sweden. rebecca.howard@dbb.su.se.

Erik Lindahl (E)

Dept. of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden. erik.lindahl@dbb.su.se.
Dept. of Biochemistry and Biophysics, Science for Life Laboratory, Stockholm University, Solna, Sweden. erik.lindahl@dbb.su.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH